优化晚期慢性病患者的酸平衡:一种质量改善倡议
1Birmingham Heartlands Hospital, Birmingham, UK laura.desai@nhs.net.
BMJ open quality
|November 25, 2025
概括
在晚期慢性病 (CKD) 中,优化血清二碳酸盐至关重要. 一个质量改进项目旨在提高最佳水平,但只显示了短期的收益,突显了在CKD管理中持续干预的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
- 改善临床质量 改善临床质量
背景情况:
- 晚期慢性病 (CKD) 经常涉及酸干扰,特别是代谢性酸症.
- 在CKD患者中纠正代谢酸性症提供了诸如减缓疾病进展和降低死亡率等好处.
- 口服二碳酸是治疗酸性疾病的成本效益较高的方法,但最佳血清二碳酸水平往往被忽视.
研究的目的:
- 提高血清二碳酸盐水平在正常范围内的晚期CKD患者的比例.
- 评估基线二碳酸盐水平和二碳酸的处方做法.
- 实施和评估质量改善干预措施,以优化CKD中的血清二碳酸盐.
主要方法:
- 在第三级脏中心进行回顾性数据收集,以确定基线二碳酸盐水平.
- 通过一系列干预措施应用质量改进 (QI) 方法.
- 在整个QI周期中监测血清二碳酸盐水平和处方做法.
主要成果:
- 基线数据显示,94%的患者的二碳酸盐水平已被检查,但只有46%的患者处于最佳范围内.
- 最初的干预措施导致了最佳二碳酸盐水平的暂时改善.
- 在随后的QI周期中没有实现持续改善,水平基本保持不变.
结论:
- 优化血清二碳酸盐是管理高级CKD的一个关键方面.
- 该QI项目提高了人们的认识,并带来了短期的改善.
- 需要进一步努力,以实现持久的变化,并将最佳的二碳酸盐管理纳入常规临床实践.
相关概念视频
01:29Renal Regulation of Acid-Base Balance
1.5K
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.5K
01:18Chronic Kidney Disease IV: Nursing Management
307
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
307
01:22Acute Kidney Injury VI: Nursing Management
371
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
371
01:20Acute Kidney Injury V: Interprofessional Care
284
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
01:28Chronic Kidney Disease III: Interprofessional Care
326
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
326
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
198
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
198